810857P
Avanti
14:0 NPS PC
1-myristoyl-2-(4-nitrophenylsuccinyl)-sn-glycero-3-phosphocholine, powder
Synonym(s):
1-tetradecanoyl-2-(4-nitrophenylsuccinyl)-sn-glycero-3-phosphocholine
Sign Into View Organizational & Contract Pricing
All Photos(2)
About This Item
Empirical Formula (Hill Notation):
C32H53N2O12P
CAS Number:
Molecular Weight:
688.74
MDL number:
UNSPSC Code:
12352211
NACRES:
NA.25
Recommended Products
Assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 100 mg (810857P-100mg)
pkg of 2 × 100 mg (810857P-200mg)
pkg of 1 × 25 mg (810857P-25mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand 810857P
shipped in
dry ice
storage temp.
−20°C
Packaging
5 mL Clear Glass Sealed Ampule (810857P-100mg)
5 mL Clear Glass Sealed Ampule (810857P-200mg)
5 mL Clear Glass Sealed Ampule (810857P-25mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
Storage Class Code
11 - Combustible Solids
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
Sorry, we don't have COAs for this product available online at this time.
If you need assistance, please contact Customer Support.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
T Kosaka et al.
Clinica chimica acta; international journal of clinical chemistry, 312(1-2), 179-183 (2001-10-03)
A spectrophotometric assay for platelet-activating factor acetylhydrolase (PAF-AH) activity differs from the radioisotopic assay in its value because of a difference in substrate specificity. The spectrophotometric assay is more precise than the radioisotopic assay, providing information that is not clear
Karl Winkler et al.
Circulation, 111(8), 980-987 (2005-02-16)
Platelet-activating factor acetylhydrolase (PAF-AH), also denoted as lipoprotein-associated phospholipase A2, is a lipoprotein-bound enzyme that is possibly involved in inflammation and atherosclerosis. This study investigates the relationship of PAF-AH activity to angiographic coronary artery disease (CAD), the use of cardiovascular
T Kosaka et al.
Clinica chimica acta; international journal of clinical chemistry, 296(1-2), 151-161 (2000-05-16)
We developed a spectrophotometric assay for serum platelet-activating factor acetylhydrolase (PAF-AH, EC 3.1.1.47.) activity using a platelet-activating factor (PAF) analogue with a 4-nitrophenyl group as substrate. PAF-AH hydrolyzes the sn-2 position of the substrate ¿1-myristoyl-2-(p-nitrophenylsuccinyl)phosphatidylcholine, producing p-nitrophenyl succinate. This liberation
M Serban et al.
Journal of cellular and molecular medicine, 6(4), 643-647 (2003-03-04)
Non-insulin dependent diabetes mellitus (NIDDM) represents an independent risk factor for cardiovascular diseases (CVD), being characterized by a continuous low-grade inflammation and endothelial activation state. Plasma platelet - activating factor - acetylhydrolases (PAF-AHs) are a subgroup of Ca(2+)-independent phospholipase A(2)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service